FUMAGALLI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 2.925
AS - Asia 1.649
NA - Nord America 938
SA - Sud America 325
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 32
OC - Oceania 1
Totale 5.947
Nazione #
RU - Federazione Russa 2.465
US - Stati Uniti d'America 888
SG - Singapore 468
CN - Cina 461
BR - Brasile 252
IT - Italia 230
HK - Hong Kong 216
VN - Vietnam 168
KR - Corea 114
DE - Germania 84
IN - India 77
BD - Bangladesh 49
AR - Argentina 35
JP - Giappone 31
FI - Finlandia 23
NL - Olanda 20
MX - Messico 19
FR - Francia 18
CA - Canada 17
EC - Ecuador 17
GB - Regno Unito 17
IQ - Iraq 14
AT - Austria 12
ZA - Sudafrica 11
IE - Irlanda 10
PL - Polonia 10
ID - Indonesia 9
UA - Ucraina 9
ES - Italia 8
CL - Cile 6
MA - Marocco 6
UZ - Uzbekistan 6
KE - Kenya 5
PY - Paraguay 4
SA - Arabia Saudita 4
VE - Venezuela 4
AL - Albania 3
BH - Bahrain 3
EG - Egitto 3
IL - Israele 3
MY - Malesia 3
PH - Filippine 3
PK - Pakistan 3
PT - Portogallo 3
TN - Tunisia 3
TR - Turchia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
PE - Perù 2
SE - Svezia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 5.870
Città #
Moscow 858
Santa Clara 238
Hong Kong 213
Singapore 182
San Jose 159
Hefei 155
Seoul 112
Ashburn 91
Ho Chi Minh City 66
Bengaluru 62
Hanoi 43
Naples 42
Munich 40
Beijing 38
Dallas 36
Los Angeles 29
Milan 26
The Dalles 23
São Paulo 21
New York 16
Nuremberg 16
Rio de Janeiro 13
Amsterdam 12
Council Bluffs 12
Rome 12
Helsinki 11
Dublin 10
Phoenix 10
Brooklyn 9
Falkenstein 9
Mexico City 9
Vitulazio 9
Memphis 8
Turku 8
Baghdad 7
Caserta 7
Chennai 7
Haiphong 7
Toronto 7
Warsaw 7
Belo Horizonte 6
Boardman 6
Brasília 6
Curitiba 6
Da Nang 6
Florence 6
Orem 6
Quito 6
Tashkent 6
Vicenza 6
Atlanta 5
Buffalo 5
Chicago 5
Formosa 5
Hải Dương 5
Johannesburg 5
Nairobi 5
Ribeirão Preto 5
Vienna 5
Angri 4
Guarulhos 4
Montreal 4
Poços de Caldas 4
San Francisco 4
Tokyo 4
Trentola-Ducenta 4
Verona 4
Asunción 3
Bari 3
Boston 3
Brescia 3
Bắc Ninh 3
Campinas 3
Campo Grande 3
Changsha 3
Concepción 3
Figino 3
Fortaleza 3
Frankfurt am Main 3
Gravataí 3
Guangzhou 3
Guayaquil 3
Kingston 3
Lappeenranta 3
Manama 3
Quilmes 3
Riyadh 3
Saint-Domineuc 3
Santo André 3
Thái Bình 3
Tianjin 3
Torre del Greco 3
Alghero 2
Ambato 2
Arezzo 2
Baku 2
Bauru 2
Biên Hòa 2
Boca Raton 2
Buenos Aires 2
Totale 2.868
Nome #
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 142
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 141
Association of Obesity with Adverse Long-Term Outcomes in Hypertrophic Cardiomyopathy 138
Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy 133
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 132
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 127
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes 125
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 122
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis 112
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis 112
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study 108
Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study 107
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 105
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 105
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 105
Anticoagulation in atrial fibrillation. A large real-world update 102
Development of an Italian version of the Leicester cough questionnaire and its relationship with other symptom-specific measures for patients with chronic cough 102
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 100
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 99
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study 96
Post-procedural fever after transcatheter aortic valve implantation: a retrospective single-centre study 96
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 94
From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy 92
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis 91
Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry 91
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 87
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy 84
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 84
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 83
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): A pilot study 83
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 83
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson–Fabry disease 80
Somatically evoked cough responses help to identify patients with difficult-to-treat chronic cough: a six-month observational cohort study 79
International patient preferences for physician attire: results from cross-sectional studies in four countries across three continents 79
PCSK9 Inhibitors “Fast Track” Use Versus “Stepwise” Lipid-Lowering Therapy in Patients with Acute Coronary Syndrome: A Retrospective Single-Center Study in a “Real-World” Population 78
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 77
Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: An unresolved problem 77
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 76
Validation of a multiple‑lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy 75
β-blockers: Their new life from hypertension to cancer and migraine 75
Prognostic impact of right ventricular dysfunction in patients with severe aortic stenosis treated with trans-catheter aortic valve implantation 74
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 74
Layman electrocardiographic screening using smartphone-based multiple‑lead ECG device in school children 74
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 73
Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis 73
Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus 73
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis 73
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 72
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 72
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 72
Change in prevalence of ATTR variants in Italy: results from a national survey 72
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis 70
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 69
Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes? 68
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 67
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry 67
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 64
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 63
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis 61
Wild-type transthyretin cardiac amyloidosis: the need for a comprehensive geriatric assessment beyond age 61
Post-procedural fever after Transcatheter Aortic Valve Implantation (TAVI). A multi-centric study 60
MitraClip implantation in real-world: clinical relevance of different patterns of left ventricular remodeling 59
Overweight and aging increase the risk of atrial fibrillation after cardiac surgery independently of left atrial size and left ventricular ejection fraction 57
Use of Smartphone-operated ECG for home ECG surveillance in COVID-19 patients 56
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 54
Development of a smartphone-based app to support the differential diagnosis in patients with primary left ventricular hypertrophy 52
Response to correspondence on 'Change in prevalence of ATTR variants in Italy' 48
Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug 42
Effects of Vericiguat on the Mitochondrial Function and Clinical Outcomes in CRT Nonresponders Patients 29
Phenotypes of Vulnerability and Prognosis in Older Adults with Cardiovascular Disease 26
Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study 25
Impatto prognostico delle sindromi geriatriche nella gestione dell’amiloidosi cardiaca da transtiretina 24
Environmental Pollutant-Induced Cardiopathogenesis Through Immune Dysfunction: The Emerging Role of Micro- and Nanoplastics 21
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact 14
A Geriatric Assessment Score Predicting 1-Year Mortality and Functional Decline After TAVR: The GASS-TAVR Study 11
Totale 5.947
Categoria #
all - tutte 18.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 0 0 0 0 2 0 0 0 3 0 1 0
2023/2024137 0 0 4 1 2 0 1 29 9 15 33 43
2024/2025947 5 42 13 61 155 116 188 47 75 79 69 97
2025/20264.681 176 427 329 194 379 2.288 238 114 173 170 96 97
2026/2027176 80 96 0 0 0 0 0 0 0 0 0 0
Totale 5.947